Technical and clinical assessment of fluorescence in situ hybridization: An ACMG/ASHG position statement. I. Technical considerations

Genetics in Medicine

Volumn 2, Issue 6, 2000, Pages 356-361

  Watson, M S ^a   Buchanan, P D ^a   Cohen, M M ^a   DeWald, G W ^a   Ledbetter, D H ^a   Goldberg, J D ^a   Wapner, R J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BIOMEDICAL TECHNOLOGY ASSESSMENT; BIRTH DEFECT; CANCER; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MUTATION; DIAGNOSTIC ACCURACY; DNA PROBE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DUPLICATION; GENETIC MARKER; HUMAN; MARKER CHROMOSOME; MENTAL DEFICIENCY; NOTE; PHENOTYPE; PLOIDY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; SEX CHROMOSOME ABERRATION;

EID: 0034520328     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/00125817-200011000-00011     Document Type: Note

References (32)

1. Prenatal interphase fluorescence in situ hybridization: Policy statement
2. Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic study on bone marrow cells after opposite sex transplantation
3. Toward quality assurance for metaphase FISH: A multicenter experience
4. A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y- chromosome probes
5. Diagnosis of CMT 1A duplications and HNPP deletions by interphase FISH: Implications for testing in the cytogenetics laboratory
6. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
7. Reproducibility of LSI HER-2/neu SpectrumOrange and CEP 17 SpectrumGreen dual color deoxyribonucleic acid probe kit
8. Incidence of low-fluorescence alpha-satellite region on chromosome 21 escaping detection of aneuploidy at interphase by FISH
9. Medical devices: Classification/reclassification; Restricted devices; Analyte specific reagents
10. Submicroscopic deletions of 16p 13.3 in Rubinstein-Taybi syndrome: Frequency and clinical manifestations in a North American population
11. Conference report: Second Annual Prader-Willi Scientific Conference
12. Prader-Willi and Angelman syndromes: Disorders of genomic imprinting
13. Contiguous gene syndromes: A component of recognizable syndromes
14. Hemozygosity at the elastin locus in a developmental disorder, Williams syndrome
15. Fluorescence in situ hybridization analysis with LIS1 specific probes reveals a high deletion rate in isolated lissencephaly
16. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus
17. Molecular confirmation of Wolf-Hirschhorn syndrome with a subtle translocation of chromosome 4
18. Evidence for a distinct region causing a cat-like cry in patients with 5p deletions
19. Smith Magenis syndrome deletion: A case with equivocal cytogenetic findings resolved by fluorescence in situ hybridization
20. Molecular cytogenetic and clinical studies of 42 patients with marker chromosomes
21. A stable acentric marker chromosome: Possible existence of an intercalary ancient centromere at distal 8p
22. The isochromosome 18p syndrome: Confirmation of cytogenetic diagnosis in nine cases by in situ hybridization
23. Parental origin of the extra chromosome in the cat-eye syndrome: Evidence from heteromorphisms and in situ hybridization analysis
24. Patient-specific probes for preimplantation genetic diagnosis of structural and numerical aberrations in interphase cells
25. Rapid detection of chromosome aneuploidies in unclutured amniocytes by using fluorescence in situ hybridization (FISH)
26. Fluorescent in situ hybridization utilization for high-risk prenatal diagnosis: A trade-off among speed, expense, and inherent limitations of chromosome-specific probes
27. Defining the efficiency of fluorescence in situ hybridization on uncultured amniocytes on a retrospective cohort of 27,407 prenatal diagnoses
28. Rapid prenatal diagnosis of aneuploidies in uncultured amniocytes by fluorescence in situ hybridization. Evaluation of >3,000 cases
29. Detection of deletions and cryptic translocations in Miller-Dieker syndrome by in situ hybridization
30. Pelizaeus-Merzbacher disease: Identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH